{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:21:00Z","timestamp":1792099260430,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.dld.2018.02.014","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T17:49:54Z","timestamp":1521395394000},"page":"668-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series"],"prefix":"10.1016","volume":"50","author":[{"given":"Romain","family":"Altwegg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Combes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Laharie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"De Ledinghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Radenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chazouilleres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Duvoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Dumortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Treton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Dharancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nachury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Goutorbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Boivineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges-Philippe","family":"Pageaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2018.02.014_bib0005","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2018.02.014_bib0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2013.03.015","article-title":"Update on primary sclerosing cholangitis","volume":"59","author":"Karlsen","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.02.014_bib0015","unstructured":"Agence de la Biom\u00e9decine. https:\/\/www.agence-biomedecine.fr\/annexes\/bilan2015\/donnees\/organes\/05-foie\/synthese.htm."},{"key":"10.1016\/j.dld.2018.02.014_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"Gizard","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.02.014_bib0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"J\u00f8rgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.02.014_bib0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/gut.43.5.639","article-title":"Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis","volume":"43","author":"Papatheodoridis","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.dld.2018.02.014_bib0035","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2013.163","article-title":"Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.02.014_bib0040","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/ajg.2013.138","article-title":"Opportunistic infections with anti-tumor necrosis factor-\u03b1 therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials","volume":"108","author":"Ford","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.02.014_bib0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2036.2012.05217.x","article-title":"Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients","volume":"36","author":"Mohabbat","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.02.014_bib0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.2012.05141.x","article-title":"The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series","volume":"36","author":"Sandhu","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.02.014_bib0055","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/apt.12256","article-title":"Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation","volume":"37","author":"Indriolo","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.02.014_bib0060","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ajg.2010.33","article-title":"Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation","volume":"105","author":"El-Nachef","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.02.014_bib0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MEG.0b013e3280116ccc","article-title":"Infliximab for ulcerative colitis following liver transplantation","volume":"19","author":"Lal","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.02.014_bib0070","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/lt.24212","article-title":"Anti-tumour necrosis alpha treatment in primary sclerosing cholangitis associated inflammatory bowel disease post liver transplantation","volume":"21","author":"Pavlidis","year":"2015","journal-title":"Liver Transplant"},{"issue":"September (9)","key":"10.1016\/j.dld.2018.02.014_bib0075","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ecco-jcc\/jjx057","article-title":"Safety of anti-TNF treatment in liver transplant recipients: a systematic review and meta-analysis","volume":"11","author":"Westerouen van Meeteren","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2018.02.014_bib0080","first-page":"449","article-title":"Cholangite scl\u00e9rosante primitive","volume":"21","author":"Chazouill\u00e8res","year":"2014","journal-title":"H\u00e9pato-Gastro Oncol Dig"},{"key":"10.1016\/j.dld.2018.02.014_bib0085","first-page":"434","article-title":"The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease","volume":"9","author":"Mosli","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.dld.2018.02.014_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135807","article-title":"Solid organ transplantation in patients with inflammatory bowel diseases (IBD): analysis of transplantation outcome and IBD activity in a large single center cohort","volume":"10","author":"Schnitzler","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2018.02.014_bib0095","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management","volume":"6","author":"Dignass","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2018.02.014_bib0100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn\u00e9s disease: current management","volume":"4","author":"Dignass","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2018.02.014_bib0105","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00042737-200512000-00018","article-title":"The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation","volume":"17","author":"Ho","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.02.014_bib0110","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2013.163","article-title":"Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.02.014_bib0115","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2018.02.014_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2036.2003.01613.x","article-title":"Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens","volume":"18","author":"Haagsma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.02.014_bib0125","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0016-5085(16)30264-5","article-title":"163 natural history of inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"150","author":"Mouchli","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.02.014_bib0130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00007890-199802150-00017","article-title":"Clinical course and management of inflammatory bowel disease after liver transplantation","volume":"65","author":"Befeler","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2018.02.014_bib0135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/003655299750026308","article-title":"Follow-up after liver transplantation for primary sclerosing cholangitis: effects on survival, quality of life, and colitis","volume":"34","author":"Saldeen","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2018.02.014_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2036.2010.04541.x","article-title":"Review article: the role of non-biological drugs in refractory inflammatory bowel disease","volume":"33","author":"Ng","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.02.014_bib0145","unstructured":"http:\/\/www.eltr.org\/Mortality-and-retransplantation.html."},{"key":"10.1016\/j.dld.2018.02.014_bib0150","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/ajg.2013.138","article-title":"Opportunistic infections with anti-tumor necrosis factor-\u03b1 therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials","volume":"108","author":"Ford","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.02.014_bib0155","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","article-title":"Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis","volume":"14","author":"Bonovas","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.02.014_bib0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn\u2019s disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.02.014_bib0165","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1572-0241.1999.01156.x","article-title":"The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis","volume":"94","author":"Shetty","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.02.014_bib0170","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.TP.0000058744.34965.38","article-title":"Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"75","author":"Vera","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.dld.2018.02.014_bib0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/gast.1996.v110.pm8566577","article-title":"Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"110","author":"Brentnall","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.02.014_bib0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.510270308","article-title":"Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation","volume":"27","author":"Loftus","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2018.02.014_bib0185","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.23741","article-title":"ncidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"19","author":"Singh","year":"2013","journal-title":"Liver Transplant"},{"key":"10.1016\/j.dld.2018.02.014_bib0190","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1600-6143.2010.03049.x","article-title":"Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis","volume":"10","author":"Sint Nicolaas","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2018.02.014_bib0195","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","article-title":"Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study","volume":"10","author":"Watt","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2018.02.014_bib0200","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1055\/s-0033-1344783","article-title":"Endoscopy in inflammatory bowel disease: recommendations from the IBD Committee of the French Society of Digestive Endoscopy (SFED)","volume":"45","author":"Peyrin-Biroulet","year":"2013","journal-title":"Endoscopy"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818302123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818302123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:08:55Z","timestamp":1761624535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865818302123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1590865818302123"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2018.02.014","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2018.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}